急诊胃镜注射组织胶治疗胃底静脉曲张破裂出血疗效观察

来源 :中国实用内科杂志 | 被引量 : 0次 | 上传用户:mllx03
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的本文重点评价GLUBRAN-2在治疗胃底静脉曲张出血中的疗效。方法 12例确诊为胃底静脉曲张出血的患者在出血发生24 h内接受胃镜下注射GLUBRAN-2,观察包括即时止血率、早期再出血率、治疗相关并发症,与再出血和死亡相关的肝功能Child分级、曲张静脉形态、预后、肝硬化病因等指标。结果 12例活动性出血的患者均达到即时止血,无再出血,未发生栓塞并发症,3例发生低热,1例死于出血后肝功能衰竭。结论急诊胃镜下注射GLUBRAN-2治疗胃底静脉曲张破裂出血疗效显著,并发症发生率低。 Objective This article focuses on the evaluation of GLUBRAN-2 in the treatment of gastric variceal bleeding. Methods Twelve patients diagnosed with variceal bleeding underwent intragastric injection of GLUBRAN-2 within 24 hours of onset of bleeding. The effects of instantaneous hemostasis, early rebleeding, treatment-related complications, and liver associated with rebleeding and death were observed Function Child grading, varicose vein morphology, prognosis, causes of liver cirrhosis and other indicators. Results All the 12 patients with active hemorrhage had immediate hemostasis, no rebleeding, no embolic complications, 3 cases of fever and 1 case of liver failure after hemorrhage. Conclusions Emergency endoscopy GLUBRAN-2 treatment of gastric variceal bleeding has a significant effect, the incidence of complications is low.
其他文献
据《Naval Forces》2001.3报道:具有30年水雷战经验、生产的450个水下航行体已在17个国家使用的法国ECA公司最近又设计了一种新型水下机器人。该公司为满足市场的新需求决定